UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 79

Sortiert nach

Determination of optical scattering properties of highly-scattering media in optical coherence tomography images

Optics express, 2004, Vol.12 (2), p.249-259

2004

Volltextzugriff (PDF)

P524: PHARMACODYNAMICALLY DEFINED METRONOMIC DOSING OF DECITABINE AND VENETOCLAX IN ACUTE MYELOID LEUKEMIA

HemaSphere, 2023-08, Vol.7 (S3), p.e90768e2-n/a

2023

Volltextzugriff (PDF)

P488: SAFETY AND EFFICACY OF VENETOCLAX PLUS “7 + 3” CHEMOTHERAPY IN NEWLY DIAGNOSED AML

HemaSphere, 2023-08, Vol.7 (S3), p.e46119b8-n/a

2023

Volltextzugriff (PDF)

Real-Time Monitoring and Evaluation of a Visual-Based Cervical Cancer Screening Program Using a Decision Support Job Aid

Diagnostics (Basel), 2016-05, Vol.6 (2), p.20

2016

Volltextzugriff (PDF)

Acute Clinical Syndrome of HLH in Patients with Hematologic Malignancy and EBV Infection

Blood, 2022-11, Vol.140 (Supplement 1), p.13244-13245

2022

Volltextzugriff (PDF)

AML-260 A Metabolically Optimized, Non-Cytotoxic Low-Dose Weekly Decitabine/Venetoclax Regimen in MDS and AML

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S282-S283

2023

Volltextzugriff (PDF)

POSTER: AML-260 A Metabolically Optimized, Non-Cytotoxic Low-Dose Weekly Decitabine/Venetoclax Regimen in MDS and AML

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S158-S158

2023

Volltextzugriff (PDF)

Portable, low-cost multispectral imaging system: design, development, validation, and utilization

Journal of biomedical optics, 2018-12, Vol.23 (12), p.1-11

2018

Volltextzugriff (PDF)

Impact of COVID-19 on case fatality rate of patients with cancer during the Omicron wave

Cancer cell, 2022-04, Vol.40 (4), p.343-345

2022

Volltextzugriff (PDF)

The development of “automated visual evaluation” for cervical cancer screening: The promise and challenges in adapting deep‐learning for clinical testing

International journal of cancer, 2022-03, Vol.150 (5), p.741-752

2022

Volltextzugriff (PDF)

Financial toxicity of hematologic malignancy therapies: Subjective experience of patients and impact on access to care

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18907-e18907

2023

Volltextzugriff (PDF)

A Non-Cytotoxic Regimen Using a Weekly Low Dose Decitabine and Venetoclax for MDS and AML in a Real World Cohort

Blood, 2022-11, Vol.140 (Supplement 1), p.6218-6219

2022

Volltextzugriff (PDF)

A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML

Clinical cancer research, 2023-08, Vol.29 (15), p.2774-2780

2023

Volltextzugriff (PDF)

Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS: Assessment of Leukemia Stem Cell Eradication By High-Resolution MRD Assay

Blood, 2022-11, Vol.140 (Supplement 1), p.3360-3361

2022

Volltextzugriff (PDF)

Contemporary use of inpatient antineoplastic (IP) treatment (Rx): Who is getting care and why?

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e18015-e18015

2019

Volltextzugriff (PDF)

A Co-Management Model for Myeloid Malignancies That Evolved during the COVID-19 Pandemic

Acta haematologica, 2023-03, Vol.146 (2), p.144-150

2023

Volltextzugriff (PDF)

A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic

Journal of neurology, 2024-06

2024

Volltextzugriff (PDF)

The development of "automated visual evaluation" for cervical cancer screening: The promise and challenges in adapting deep-learning for clinical testing: Interdisciplinary principles of automated visual evaluation in cervical screening

International journal of cancer, 2022-03, Vol.150 (5), p.741-752

2022

Volltextzugriff (PDF)

Non-destructive label-free monitoring of collagen gel remodeling using optical coherence tomography

Biomaterials, 2010-11, Vol.31 (32), p.8210-8217

2010

Volltextzugriff (PDF)

Quantitative characterization of developing collagen gels using optical coherence tomography

Journal of Biomedical Optics, 2010-03, Vol.15 (2), p.026019-026019

2010

Volltextzugriff (PDF)

Dermal reflectivity determined by optical coherence tomography is an indicator of epidermal hyperplasia and dermal edema within inflamed skin

Journal of Biomedical Optics, 2011-04, Vol.16 (4), p.040503-040503

2011

Volltextzugriff (PDF)

Optical characterization of vascular tissue constructs made with soluble vs. homogenized collagen

The FASEB journal, 2008-03, Vol.22 (S1)

2008

Volltextzugriff (PDF)

BENEFIT PLAN MAXIMIZING: HOW TO KEEP A BENEFIT PROGRAM ATTRACTIVE DURING DIFFICULT ECONOMIC TIMES

Life Insurance Selling, 2009-11, Vol.84 (11), p.29

2009

Volltextzugriff (PDF)

Hidden killers: human fungal infections

Science translational medicine, 2012-12, Vol.4 (165), p.165rv13

2012

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(79)

Sprache

Englisch
(79)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Determination of optical scattering properties of highly-scattering media in optical coherence tomography images

P524: PHARMACODYNAMICALLY DEFINED METRONOMIC DOSING OF DECITABINE AND VENETOCLAX IN ACUTE MYELOID LEUKEMIA

P488: SAFETY AND EFFICACY OF VENETOCLAX PLUS “7 + 3” CHEMOTHERAPY IN NEWLY DIAGNOSED AML

Real-Time Monitoring and Evaluation of a Visual-Based Cervical Cancer Screening Program Using a Decision Support Job Aid

Acute Clinical Syndrome of HLH in Patients with Hematologic Malignancy and EBV Infection

AML-260 A Metabolically Optimized, Non-Cytotoxic Low-Dose Weekly Decitabine/Venetoclax Regimen in MDS and AML

POSTER: AML-260 A Metabolically Optimized, Non-Cytotoxic Low-Dose Weekly Decitabine/Venetoclax Regimen in MDS and AML

Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer

Portable, low-cost multispectral imaging system: design, development, validation, and utilization

Impact of COVID-19 on case fatality rate of patients with cancer during the Omicron wave

The development of “automated visual evaluation” for cervical cancer screening: The promise and challenges in adapting deep‐learning for clinical testing

Financial toxicity of hematologic malignancy therapies: Subjective experience of patients and impact on access to care

A Non-Cytotoxic Regimen Using a Weekly Low Dose Decitabine and Venetoclax for MDS and AML in a Real World Cohort

A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML

Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS: Assessment of Leukemia Stem Cell Eradication By High-Resolution MRD Assay

Contemporary use of inpatient antineoplastic (IP) treatment (Rx): Who is getting care and why?

A Co-Management Model for Myeloid Malignancies That Evolved during the COVID-19 Pandemic

A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic

The development of "automated visual evaluation" for cervical cancer screening: The promise and challenges in adapting deep-learning for clinical testing: Interdisciplinary principles of automated visual evaluation in cervical screening

Non-destructive label-free monitoring of collagen gel remodeling using optical coherence tomography

Quantitative characterization of developing collagen gels using optical coherence tomography

Dermal reflectivity determined by optical coherence tomography is an indicator of epidermal hyperplasia and dermal edema within inflamed skin

Optical characterization of vascular tissue constructs made with soluble vs. homogenized collagen

BENEFIT PLAN MAXIMIZING: HOW TO KEEP A BENEFIT PROGRAM ATTRACTIVE DURING DIFFICULT ECONOMIC TIMES

Hidden killers: human fungal infections

Suchergebnisse filtern